Lantern Pharma Inc.
LTRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001763950
No open-market purchases or sales by Lantern Pharma Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $12.0M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Lantern Pharma Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 26 | 23 | −3 |
| Shares | 1.44M | 1.07M | −370.9K (−25.8%) |
| Value | $6.84M | $5.40M | −$1.45M (−21.1%) |
New holders (3)
Institutions that held Lantern Pharma Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 15,134 | $91.4K | 0.00% |
| Lynwood Capital Management Inc. | 12,000 | $73.0K | 0.09% |
| Bank of America Corp | 8 | $48 | 0.00% |
Sold out (6)
Institutions that held Lantern Pharma Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Sanders Morris Harris LLC | 365,930 | $1.72M |
| Susquehanna International Group, LLP | 14,558 | $70.0K |
| JPMorgan Chase & Co | 1,787 | $9.00K |
| Simplex Trading, LLC | 373 | $1.00K |
| Royal Bank of Canada | 87 | $0 |
| Bogart Wealth, LLC | 75 | $0 |